EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ATAI: Atai Life Sciences N.V.

01 May 26 15:59
LAST:

4.130

CHANGE:
 0.02		OPEN:
4.170		HIGH:
4.309		ASK:
6.000		VOLUME:
1.85M
CHG(%):
0.48		PREV:
4.160		LOW:
4.085		BID:
0.010		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
01 May 264.1504.1954.0854.1402.36M
30 Apr 264.1204.1854.0104.1604.19M
29 Apr 264.3304.3504.0504.1203.63M
28 Apr 264.2904.5004.2254.3303.25M
27 Apr 264.6004.7504.3304.3405.17M
24 Apr 264.8504.8804.5204.6305.98M
23 Apr 264.8004.8904.6004.7708.48M
22 Apr 264.9605.0004.6304.7106.64M
21 Apr 264.9905.1854.6534.87014.77M
20 Apr 265.0305.5104.8004.90047.14M

PROFILE

Name:Atai Life Sciences N.V.
About:Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic in Phase 2a trial for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists in preclinical studies for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Amstelveen, The Netherlands.
Sector:Healthcare
Industry:Biotechnology
Address:Prof. J.H. Bavincklaan 7, Amstelveen, Netherlands, 1183 AT
Website:https://atai.com
CIK:0001840904
ISIN:NL0015000DX5
FIGI:BBG0107FR3K9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:4.222.1%
MA10:4.508.9%
MA20:4.171.1%
MA50:3.896.2%
MA100:3.925.4%
MA200:4.263.2%
STO9:1.88 
STO14:17.47 
RSI14:57.99
WPR14:-72.38
MTM14:0.29
ROC14:0.08 
ATR:0.40 
Week High:4.8818.2%
Week Low:4.013.0%
Month High:5.5133.4%
Month Low:3.543.2%
Year High:6.7563.4%
Year Low:1.29220.2%